For adolescents, contact sports increase the risk of brain health complications.
Despite disappointing results, tenecteplase's story in stroke treatment might not be over.
A survey showed 67.3% of patient advocacy organizations received industry funding, while 11.9% received more than half of their funding from industry.
Ronald Petersen, MD, PhD, discusses the implications of Eli Lilly's failed solanezumab trial on the future of Alzheimer's disease research.
Katherine A. Roberts, MD, FACE, ECNU, discusses her choice to opt out of Medicare and offers advice to physicians considering doing the same.
Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.
Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.
Key opinion leaders weigh in given recent findings that increased use of therapeutic coma in status epilepticus may not be linked with improved outcomes.
The greatest hurdle in developing effective treatments for TBI lies in the varied and dynamic pathophysiology and incomplete understanding of factors leading to poor outcome.
HIPAA doesn't require providers to encrypt devices or electronic information, but one could say it is strongly encouraged.
Despite 3 large randomized trials and updated guidelines, the question of PFO closure remains a complex entity.
Huma Sheikh, MD, discusses some of her top picks from presentations made at the 2016 AHS annual meeting.
A joint medical and surgical approach may ensure the best outcome.
The idea of low-dose tPA will likely not be abandoned despite recent findings.
Ticagrelor may have an opportunity to shine in patients already on aspirin or clopidogrel.
Changing the stigma around and frequency of injury in football requires a collaborative, educational effort involving all stakeholders.
Dr Albert Favate addresses some of the hottest topics concerning stroke care and patient management.
Dr Conidi discusses some of the major points addressed in the blockbuster film that could impact clinical practice.
Ruben Kuzniecky, MD, outlines what to expect at this year's American Epilepsy Society Annual Meeting.
Interventional stroke treatment continues to rapidly evolve as health care providers implement new protocols to ensure more rapid, successful treatment.
Technology called Brain Network Activation allows health care professionals to evaluate brain network function after traumatic brain injury and during recovery.
New recommendations for the treatment of acute stroke put emergency physicians and neurology stroke specialists at odds.
The ongoing INTREPID clinical trial is evaluating the safety and effectiveness of the Vercise™ DBS System.
Steven Croft, MD, lays down his reasons why ICD-10 will do more bad than good for physician and patient communities.
The meeting was abuzz with excitement about a new potential treatment targeted directly at migraines.
Huma U. Sheikh, MD, shares her thoughts on sessions of interest from the upcoming AHS Annual Scientific Meeting.
The RiverSpring at Night program accommodates the altered sleep cycles of Alzheimer's dementia patients with a drug-free approach to nighttime activities and comprehensive care.
Michael Ronemus, PhD, was forced to step out from behind the microscope when his own son was diagnosed with autism.
Lynn Webster, MD, calls out media reports on a new study that claims opioid use during pregnancy may be harmful to infants.
A multidisciplinary team of providers come together to address epilepsy cases of patients with limited access to care.
All too often, physicians, coaches, and athletes are swayed into making a quick conclusion about concussion risk after a hard hit.
Results of a twin study showed that insomnia was moderately heritable, but in childhood, it was thought to be a result of behavior.
Kamil Ugurbil, PhD, is leading the monumental 5-year Human Connectome brain imaging project that's making use of 7T MRI technology.
Changes made to autism spectrum disorders in DSM-5 have implications for how Asperger's is diagnosed and treated.
The long-awaited results of the MR CLEAN trial are sure to affect the future of acute stroke treatment.
Prejudice against pharma-funded research could have an ill effect on the health-care industry.
The latest genetic theory suggests autism's sporadic nature might be due to de novo mutations arising in the parental germline.
More powerful MRI helps researchers map brain fiber pathways to better understand diseases like Alzheimer's, autism, MS, and TBI.
Emphasizing the importance of exercise, good nutrition and meditation as treatment adjuncts can benefit patient outcomes.
Williams' suicide emphasizes the importance of support for patients with Lewy Body Dementia and their families.
Brittany Maynard's physician-assisted suicide has reignited the "death with dignity" debate that challenges the ethical standards of the medical profession.
ADHD is often found in patients complaining of other illnesses, yet the former often goes untreated in those circumstances.
Hypnotic suggestion nearly doubled slow wave sleep in suggestible females, researchers found.
Screening for speech deficiencies at each visit can identify potential delays and target interventions to achieve milestones.
Nocturnal seizures can easily be confused with parasomnias, including confusional arousals, cataplexy and REM sleep-behavior disorder.
Neurology Advisor Articles
- Efficacy of Cladribine Tablets in Patients With Relapsing Multiple Sclerosis
- Cognitive Performance, Mood Deficits, White Matter Hyperintensities in Migraine
- Disrupted Thalamo-Striato-Hypothalamic Function May Serve as a Good Biomarker for Parkinson Disease
- FDA to Review Sublingual Tx for Motor Fluctuations in Parkinson Disease
- Shortened MS Quality-of-Life Questionnaire Compares With Longer Test in Reliability and Consistency
- Polyphenol-Rich Diet May Reduce Dementia Risk in Older Adults
- Addressing Migraine That Mimics Stroke
- Visual Association Test, MMSE Highly Predictive of Dementia in Older Adults
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Medical Cannabis Shows Promise in Treating Symptoms of Multiple Sclerosis
- Rituximab Effectively Reduces Disease Activity in Multiple Sclerosis
- Characteristics, Treatment Response Similar in Idiopathic, 22q11.2 Deletion Syndrome-Associated Parkinson Disease
- Lifestyle, Behavioral Factors Contribute to Dementia Risk Assessment
- FDA Lifts Clinical Hold on Trial for Duchenne Muscular Dystrophy Treatment
- Fremanezumab Chronic Cluster Headache Study Discontinued